Home » Hospira Gains Global Biogeneric Rights From Teva
Hospira Gains Global Biogeneric Rights From Teva
Hospital products and generic drugmaker Hospira Inc said it acquired worldwide rights to a generic version of the white blood-cell boosting drug filgrastim from Teva Pharmaceutical Industries Ltd.
Yahoo! Finance UK & Ireland
Yahoo! Finance UK & Ireland
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May